In the recent case of Eike v. Allergan, Inc., 7th Cir. 2017, the United States Court of Appeals for the Seventh Circuit addressed the admissibility and impact of testimony from an Antitrust Expert Witness in a class action alleging anticompetitive conduct by pharmaceutical manufacturers. This case exemplifies the critical role of expert economic analysis in antitrust litigation and the rigorous scrutiny such testimony faces under the Daubert standard.
Background and Parties
The plaintiffs, representing eight certified classes of consumers in Illinois and Missouri, alleged that six pharmaceutical companies, including Allergan, Inc., manufactured glaucoma eye drops in unnecessarily large sizes. Plaintiffs claimed this practice was wasteful, increased costs, and constituted a violation of state consumer protection statutes. The defendants countered that the size of the eye drops was medically justified and approved by the FDA.


